Haseeb Abdul, Zeb Muhammad, Ahmed Immad, Ahmad Shah Jamal, Moosa Muhammad, Hussain Rafaqat, Raheel Muhammad, Tayyib Muhammad, Muhammad Raza
Urology, Institute of Kidney Diseases, Hayatabad Medical Complex Peshawar, Peshawar, PAK.
General Surgery, Hayatabad Medical Complex Peshawar, Peshawar, PAK.
Cureus. 2025 Jan 19;17(1):e77660. doi: 10.7759/cureus.77660. eCollection 2025 Jan.
The objective of this study is to evaluate the outcomes and complications of transurethral resection of the prostate (TURP) in patients with and without acute urinary retention (AUR).
This descriptive study was conducted in the Urology Department of the Institute of Kidney Diseases (IKD), Hayatabad Medical Complex (HMC), Peshawar, from 11th August 2023 to 11th February 2024. A total of 127 male patients aged over 40 years with prostate sizes between 40 and 80 grams on ultrasonography were included. Patients with a history of prostate cancer or prior prostate surgery were excluded. All participants underwent TURP, and postoperative complications, such as urinary tract infections (UTIs), hematuria, lower urinary tract symptoms (LUTS), recatheterization, and hospital stay length, were documented. Statistical analysis was performed using IBM SPSS Statistics for Windows, Version 23 (Released 2015; IBM Corp., Armonk, New York, United States) to compare outcomes between the AUR and non-AUR groups.
The study included 127 patients with a mean age of 64.92 ± 3.8 years. The incidence of AUR was 63(49.6%). Postoperative complications such as UTIs (p=0.39), hematuria (p value= 0.06), LUTS (p=0.27), recatheterization (0.52), and sepsis (0.20) were more common in the AUR group, though these differences were not statistically significant. The need for blood transfusions was also higher in the AUR group (P=0.09). Hospital stay duration and symptom resolution were comparable between the AUR and non-AUR groups.
AUR in benign prostatic hyperplasia patients was associated with more severe symptoms and an increased frequency of certain postoperative complications, including UTIs, hematuria, and the need for blood transfusions. However, most differences between the AUR and non-AUR groups were not statistically significant.
本研究旨在评估经尿道前列腺切除术(TURP)在有和没有急性尿潴留(AUR)的患者中的治疗效果及并发症。
本描述性研究于2023年8月11日至2024年2月11日在白沙瓦哈亚塔巴德医疗中心(HMC)肾脏病研究所(IKD)泌尿外科进行。纳入了127例年龄超过40岁、超声检查前列腺大小在40至80克之间的男性患者。排除有前列腺癌病史或既往有前列腺手术史的患者。所有参与者均接受了TURP,并记录了术后并发症,如尿路感染(UTIs)、血尿、下尿路症状(LUTS)、再次导尿和住院时间。使用IBM SPSS Statistics for Windows,版本23(2015年发布;IBM公司,美国纽约州阿蒙克)进行统计分析,以比较AUR组和非AUR组的治疗效果。
该研究纳入了127例患者,平均年龄为64.92±3.8岁。AUR的发生率为63例(49.6%)。术后并发症如UTIs(p=0.39)、血尿(p值=0.06)、LUTS(p=0.27)、再次导尿(0.52)和脓毒症(0.20)在AUR组中更常见,尽管这些差异无统计学意义。AUR组输血需求也更高(P=0.09)。AUR组和非AUR组的住院时间和症状缓解情况相当。
良性前列腺增生患者的AUR与更严重的症状以及某些术后并发症(包括UTIs、血尿和输血需求)的频率增加有关。然而,AUR组和非AUR组之间的大多数差异无统计学意义。